Réduction du risque cardiovasculaire par la médecine physique en milieu de travail à la Société Nationale d'Electricité

CONCLUSION

Ce travail décrit une population en milieu de travail caractérisée par un haut risque cardiovasculaire.

Ce haut risque cardiovasculaire, ignoré par cette population,est constitué des fréquences très élevées d'hypertension artérielle, d'inactivité physique, d'obésité, de diabète sucré, d'hypercholestérolémie totale, de tabagisme par cigarettes et de consommation excessive d'alcool.

La prise en charge basée uniquement sur un programme d'activités physiques a eu un impact significatif sur la réduction du niveau de risque cardiovasculaire dans cette population.

RECOMMANDATIONS

Au seuil de ce travail, les recommandations suivantes sont formulées :

- au Ministère de la Santé publique de rendre effectif le programme de lutte contre les maladies chroniques non transmissibles ;

- aux Médecins et aux autres Professionnels de la santé de considérer le traitement non pharmacologique des maladies chroniques non transmissibles comme fondement de tout traitement médicamenteux et de réhabilitation ;

- aux Responsables du département de Médecine Physique d'encourager les étudiants dans la prévention et la recherche pour la promotion de la santé cardiovasculaire ;

- aux Cadres dirigeants de la SNEL d'utiliser les données de la présente étude pour redynamiser la Médecine du travail.

REFERENCES

1. PRUSKA P., TUOMILEHTO, TNISSINEN A., VARTIAINEN E., The North Karelia project. 20 years. Result and Experience. Helsinki, University Printing House, Helsinki, 1995.

2. MARSQUES- VIDAL P. TUOMILEHTO J. Hypertension awareness, treatment and control in community: is the «rule of halvs» still valid?

J Hum hypertens 1997; 11: 213 - 220.

3. DONNISON CP, Blood pressure in the African native: It's bearing upon

the aetiology of hyperpression and arterial sclerosis. Lancet 1929; 1: 6 - 7.

4. WORLD HEALTH ORGANIZATION, Non commicable diseases: A strategy for the African region who regional office for Africa, Harare 2000.

5. BEEVERS DG, PRINCE JC, Hypertension: an emerging problem in Hospital countries royal trop Med Hy 1991, 85 : 324 - 326.

6. LONGO - MBENZA B, TONDUANGU, MUYENO, PHANZU et al. Predicators of stroke associated mortality in Africans. Revue Epidem et santé publique 2000, 48: 31-35.

7. LONGO - MBENZA B, Smoking and war induced stress are identified as cardiovascular and impaired glucose tolerance risk factors in Congolese. out patients, 12^th world conference on tobacco a Health - 3 - 8 august 2003, Helsinki, Finland: 60 (Abstract).

8. LONGO - MBENZA B, LUKOKI LUILA, VANGU NGOMA D, MBUNGU S, Cigarette smoking, gender Menopause and coronary heart disease In sub Saharan Africa: A clinic - based study. 12^th World conference on Tobacco or Health.

3-8 August 2003, Helsinki, Finland: 61 (Abstract)

9. LONGO - MBENZA B, LUKOKI LUILA E, Stroke incidence and cigarette smoking in hypertensive Africans : a Clinic - based study. 12^th World conference on Tobacco or Health. 3-8 August 2003 Helsinki, Finland: 61 (Abstract)

10. LONGO - MBENZA B, LUKOKI LUILA E. Tobacco smoking and other risk factors for coronary heart disease in sub Saharan African A clinic-based study. 12^th world conference on Tobacco or Health. 3 - 8 August 2003, Helsinki, Finland: 61 (Abstract).

11. LONGO - MBENZA B cigarette smoking, alcohol in take and fibrinogen in African hypertensive 12^th world conference on Tobacco or Health. 3 - 8 August 2003, Helsinki, Finland : 62 (Abstract).

12. MBALA MUKENDI M. Obésité, distribution des graisses, pression artificielle et prévalence de l'hypertension artérielle dans une population active. Mémoire de spécialisation, Université de Kinshasa, 1994.

13. NKOY BELILA J. Facteurs de risque cardiovasculaire, maladies cardiovasculaires et gradient social en milieu professionnel. Mémoire de spécialisation, université de Kinshasa, 2002.

14. CIBAGEYGYSA. Qualité de la vie dans les affections cardiovasculaires en pratiques quotidienne, Information Médicale et pharmaceutique. Bâle suisse. Ed. F.B. Buirdwoood. 1987.

15. BERTRAND Ed, KACOU GM, MONKAM M. Maladie coronaire, sous développement et développement : comment le développement économique favorise -t-il les maladies coronaires ? Cardial tropical 1884, 10 (n°spécial) : 51 - 64

16. PYORALA K., SAVOLAINE N. ,KAUKOLAS S. ,HAAPAKOSKI J. , Plasma insulin as coronary heart disease risk factors ; relation ship to other risk factors and predictive values during 91/ 2 year follow-up of the Helsinki policeman population. Acta Med scand (suppl) 1985;710:38-82.

17. Wilmore, Costill. Physiologie du sport et de l'exercice physique, éditions, De Boeck University, 1998.

18. Mac ARDLE WD, KATCH F, KATCH V. Physiologie de l'activité physique. Energie, nutrition et Performance, Vigot Editions, 2^ème Editions, paris, 1987.

19. FOREYT JP. et al : weight control and nutrition education programs in occupation settings . Pubic Health Reports, 95:127,1980.

20. ANGLADE C., CRETIN C., BASSET B., CHAULIAC M., OPPERT J.M., La prévention des maladies cardiovasculaires. Les actions et programmes de prévention. Actualité et dossier en Santé Publique, 1243-275X, 2004 /06,N :47 ;23-33

21. BLAIR SN. Physical activity fitness,and health. Res Q Exercise, Sport, 1993;64: 365-376.

22. PAFFENBARGER RS JR, HYDERT, WING AL. LEEIM, JUNG DL, KAMPET

JB., The association of changes in physical-activity level and other lifestyles characteristics with mortality among men. New Engl. J. Med 1993; 328:538-545.

23. SHEPARD RJ Physical activity and reduction of health risks: how fare the benefits independent of fast loss. J Sport Med Phy Fit 1994; 34:91-98.

24. OPPERT J.M., Gautier J.F.,

Rôle de l'activité physique dans le traitement de l'obésité et du diabète de type 2.

Métab. Horm. Nut., 2000.

25. DESSANGES J.F, Spirométrie AARC Clinical Practice guideline, Spirométrie, 1996 Update.

26. MONOD H., FLANDROIS R.,

Bases physiologiques des activités physiques et sportives.

Ed. Masson, 9^ème édition.

27. Carré F, La surveillance cardiologique du sportif, édition Masson, paris, 1988.

28. SAINT PIERRE F. BROCKMAN J.P.

Fréquence cardiaque chez le sportif amateur. www.medisite.fr

29. PASSEROM J.,

Guide pratique des facteurs de risque cardiovasculaire, MMI, éditions Masson.

30. La tension artérielle. www.EasyGym.com

31. ADA. The expert committee on the Diagnosis and classification of diabetes mellitus. Diabetes care.1997; 20: 1183-97.

32. HEINE RJ, BALKAU B., CERIELLO A, DEL PRATO S., HORTON ES., TASKINEN MR. What does postprandial hyperglycaemia mean? Diabetic Med 2004; 21:208-13.

33. COOPER K., Oxygène à la carte, Editions D.T., Dammarie les lys, France, 1981

34. VRIJENS G., Entraînement raisonné du sportif, De Boeck université 1991.

35. MAGORIGH F., BATTISTA E., Hygiène et prophylaxie par les exercices physiques

Vigot frères, Editions, 23 rue de l'école de Médecine, paris 6^ème.

36. KARVONEN J., Physiological follow up of endurance runners. Report for the finish sports foundation, 1983.

37. POLLOCK, M.L, the quantification of endurance training programs. In exerc sports sci rev, vol.I, edited by Wilmore. New York, Academic Press, 1973.

38. VERSON T. Anatomo-physiologie ( http://person.infonie.fr/T.verson)

39. BLAIR, SN, GOODYEAR, N.N., GIBBORS, L.W et COOPER, Physical fitness and incidence of hypertension in healthy normotensive men and women journal of the American Association, 1984.

40. BLAIR S.N, KOHL H.W, PATTENBARGER R.S, CLARK D.G, COOPER K.H et CIBBORS L.W, Physical fitness and all cause mortality. A prospective study of healthy men and women. Journal of the American Medical Association, 1989

41. CARLSON M. C., STEIN J. H., Cardiovascular diseases and the aging women: overcoming barriers to lifestyle changes, current women's health, reports, 2002;2: 366-372.

42. OMRAN AR, The epidemiologic transition, a key of the epidemiology of population change. Milibank memorial Fund. Q.1971; 49:509-538.

43. LONGO MBENZA B, TONDUANGU, MUYENO, PHANZU et al. Predictors of stroke associated mortality in Africans. Rev. Epidem et Santé publique 2000, 48: 31 - 39.

44. ONYUMBE W.G, la problématique de la privatisation des entreprises publiques en République Démocratique du Congo, Cas de la Société Nationale d'Electricité. Mémoire de spécialisation de Master en management public, Université William Booth, 2004.

45. BRUCKERT E, EMMERICH J, DE LAHAYE F. et al. Rôle des triglycérides dans les maladies cardio-vasculaires. Arch Mal coeur 1992, 85(III) 29-35.

46. KHOSLA T., LOWE CR. Obesity and smoking habits by social class.

Br J prev soc Med 1972; 26:249-256.

47. GNIZE L, ILIOU L. Le traitement de facteurs de risque de l'athérosclérose coronaire. Arch. mal coeur 1992 ; 85 :1687-93.

48. KHOSLA T., LOWE CR. Obesity and smoking habits by social class.

Br J prev soc Med 1972; 26:249-256.

49. SROLE L, FISHER AK. The social epidemiology of smoking behavior 1993 and 1970. The Midtown Manhattan Study. Soc. Sc. Med 1973; 7:341-358.

50. MARMOT M.G, ROSE G, SHIPLEY M, HAMILTON PJS, Employment grade and coronary heart disease in British civil servants.

J Epidem Comity Health 1978, 32: 244-249.

51. HOLME I, HELGELAND A, HJERMANN I, LUND-LARSEN PG, LEREN P.,

Coronary risk factors and socio economics statutes, the Oslo Study.

Lancet 1976; 11, 1396-1398.

52. CHARLES D, BARABE P. et TALBI D., Infarctus du myocarde en algérie. Cardial Trop 1982, 8:13-19.

53. LONGO MBENZA B, Smoking and wars induced stress are identified as cardiovascular and impaired glucose tolerance risk factors in Congolese outpatients. 12th world conference on tobacco or health. 3-8 august 2003, Helsinki, Finland: 60 (Abstract).

54. MANANGA OC, BABAKA M, UMBA G.

Tabagisme par cigarette en milieu de travail de la ville de BOMA. Travail de fin de cycle, Université Kasavubu 2003

55. LONGO MBENZA B, LUKOKI, LUILAE, VANGU, NGOMA D, MBUNGU S, Smoking prevalence among Africans at work place: socio demographic inequalities and cardiovascular risk, 12th world conference on tobacco or health. 3-8 August 2003, Helsinki, Finland.

56. Joint National Comities on detection. Evaluation and treatment of high blood pressure. Arch intern med 1988; 148: 1023-38.

57. BOFETTA P, GARFINKEL L., Alcohol drinking and mortality among men enrolled in an American cancer society prospective study. Epidem 1990 ; 1:342-348.

58. LEIZOROVICZ A. Cholestérol et risque cardiovasculaire.

La revue du Praticien, supplément n°5

Rev.Prat. (Paris), 1988, 38 ; 5 : 42.

59. REIMS HM, KJELDSEN SE, BRADY WE, DEVEREUX RB, JULIUS S, BEEVERS G and al.

Alcohol consumption and cardiovascular risk in hypertensive with left ventricular hypertrophy: The LIFE Study.

60. REYNOLDS K, LEWIS B, NOLEN JD, KINNEY GL, SATHYA B. Alcohol consumption and risk of stroke a meta-analysis JAMA 2003, 289.

61. DANIEL S. BERECZKI D.

Alcohol as a risk factor for hemorrhagic stroke. Ideggyogy SZ 2004; 57 (7-8):247-56

62. ELKIND MS, SCIACCA R., BODEN-ALBALA B. RUNDEK T., PAIK MC, SACCO RL. Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan study, stoke 2006; 37 (1): 13 - 9.

63. GOLDEIN LB.

Is there a causal relationship between the amount alcohol consumption and stoke risk? Stoke 2006; 37(1): 1-2.

64. THOMAS D, GILES MD; GARY SANDER, MD, PH D.

Alcohol - A cardiovascular drug. The American journal of geriatric cardiology 2005, 14; 3: 154-158.

65. BURGER M., BRONSTRUP A, PIETRZIK K.,

Derivation of tolerable upper alcohol intake levels in Germany, a systematic review of risks and benefits of moderate alcohol consumption. Prev Med 2004; 39:111-112.

66. MALINSKI MK, SESSO HD, LOPEZ-JIMENEZ F., BURING JE, GAZIANO JM.

Alcohol consumption and cardiovascular disease mortality in hypertensive men. Intern Med 2004: 164 (6 623-628.

67. MUKUMAL KJ, ASCHERIO A., MITTLEMAN MA, CONIGRAVE KM, CAMARGO CA JR., KARACHI I, STAMPFER MJ, WILLETT WC, RIMM EB.

Alcohol and risk for ischemic stroke in men the role of drinking patterns and usual beverage. Ann Intern Med 2005, 142 (1): 124.

68. ZHANG LF, ZHAO LC., ZHOO BF., YANG J., LI Y., WU YF.

Alcohol consumption and incidence of ischemic stroke in male Chinese. Zhonghua Lui Xing Bing Xue Za Zhi 2004; 25 (11) : 954 - 7.

69. FOWLER SB., MOUSSOUTTAS M., MANCINI B.,

Metabolic syndrome: contributing factors and treatment strategies. J Neurosci Nurs 2004; 37(4) : 220-2023.

70. PARK HS, CHO SI, SNG YM., SUNG J., Multiple metabolic risk factor and in men with low prevalence of obesity Atherosclerosis 2005; Epub ahead of print.

71. HU G., SARTI C., JOUSILAHTI P.,SILVENTOINEN BARENGO NC.,TUOMILEHTO J.

Leisure time, occupational, and commuting physical activity and the risk of stroke. Stroke, 2005; 36 (9: 1994-1999.

72.BONORA E. The metabolic syndrome and cardiovascular disease. Ann Med 2006; 38: 64-80.

73.MALKOVA J., ANDEL M. STOLBA P., KMLOVA I., Hyperinsulinemia - the common denominator in type II diabetes mellitus, obesity, hypertension, hypertriglyceridemia and atherosclerosis Cas Lek Cesk 1994; 133 (2): 41-45.

74. SINGH RB., NIAZ MA., AGARWAL P., BEGUM R. RASTOGI SS., SINGH NK.,

Epidemiologic study of central obesity insulin resistance and associated disturbances in the urban population of North India. Acta Cardiol 1995; 50 (3): 215-225.

75. LONGO MBENZA, BIELELI E, VANGU N, DITU M.S., The role of really hemodynamic impairment and disease duration on diabetic cardiomyopathy and hypertension in central Africans with arteries sclerosis. J Diabetes complications 2001, 15:1-7.

76. BENETOS A., SAFAR M., RUDNICHI A., SMULYAN H., RICHARD J.L., DUCIMETIERE P., GUIZE L., Pulse pressure : a predicator of long terme cardiovascular mortality in french male population. Hypertension 1997; 30(6): 1410-1415.

77. SHEPHARD, R.J. Intensity, duration and frequency of exercise s determinants of the response to a training regime. In Z. Angew. Physiol, 1968.

78. WELBORN T., WEARNEK K .Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentration. Diabetes care 1979; 2: 154 - 160.

79. TOLL A. And SMALL D.M, Currents concepts: plasma high density lipoproteins. N. Engl J. Med, 1978.

80. HASKELL W.L., The influence of exercise training on plasma lipids and lipoproteins in health and disease. Acta Medica Scandinavica, 1986.

81. KIRKCALDY B., Exercise as a therapeutic modality medicine and sports science, 29, 166-187, 1989.

82. PETRUZZELO S.J, LANDERS JM., HATFIELD B.D., KUBITZ K.A et SALAZAR W.. A meta-analysis on the anxiety reducing effects of acute and chronic exercise outcomes and mechanisms. Sport Medicine, (1991); 11,:143-182.

83. DESPRES J.P., Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ. 2001; 322: 716-720.

84. YUSUF et al, Effect of potentially modifiable risk factors associate with myocardial infarction in52 countries (the INTERHEART study): case control study. The lancet, volume 36, number 9438, September 11-17, 2004.

85. SCHOUL JM, ARMAND B, DOCI METERE P, CHABDS D, BRAU J. et al. Comparison of risk factors in vasospastic angina without significant fixed coronary narrowing to significant fixed coronary narrowing and no vasospastic angina. Am J Cardiol 1986; 57: 199 - 202.

86. World Health Organisation/International Society of Hypertension. Pratice guidelines for primary care physicians. J hypertens 1999, 17: 151 - 8.

87. FREIDMAN M, THORESEN CE, GILL JY et al. Determination of type a behavior and its effect on cardiac recurrences in post myocardial infarctus patients: summary results of the recurrent coronary prevention project. AM Heart J. 1986; 112: 653-64.

88. SHARMA AM., Adipose tissue: a mediation of cardiovascular risk. International journal of obesity, volume 26, suppl.55-57

89. DESPRES J.P. Treatment of obesity: need to focus on high risk abdominally obese patients BMJ. 2001; 322:716-720.

90. SHARMA AM, Adipose tissue: a mediatior of cardiovascular risk

International journal of obesity, volume 26, suppl. 24: 34-35.

91. FORDES, MOKDOD AH, GILES WH, Trends in waist circumference among us adults. Obes. Res 2003.

92. OKOSUN IS, CHANDRA KM, BOER A, et al Abdominal adiposity in us adults: prevalence and trends, 1960-2000. Prev Med.2004.

93. KHAN JP, RADEL C, RAUTURE P, Aspects psychologiques et psychiatriques des obésités. Ed. Techniques. Encyclopédie Méd. Chir. (Paris, France). Endocrinologie, 10506 Med Afr. Noire 1999; 46 (2) ; 548-553.

94. WADDENTA, STUNKAR D et al. Social and psychological consequences of obesity, Ann Inter Med 1985 ; 103 : 1062-1067.

95. American College of Sport Medicine 1990. The recommended quantity and quality of exercise for developping and maintaining cardiorespiratory and muscular fitness in healthy adults. Medicine and science in Sports exercise, 22: 265-274.

96. SHERPHARD, RJ, et al; Development of the Canadian home fitness test. Can Med. Assoc, 1976

97. HICKSON, R.C. et al. Time course of the adaptive response of aerobic power and heart rate to training. Med Sci sports Exerc, 1981.

98. JAMES, S Injuries to runners. An J Sports Med, 1978.

99. GETTMAN, L.R. et al.Physiological responses of men to 1, 3 and 5 days per week programs. Res. Quart, 1976.

100. POLLOCK, M.L, et al, Effects of frequency and duration of training on attrition and incidence of injury. Med. Sci. Sports, 1977.

101. KANNEL W, WOLF P.A, MC GEC DL, DAW B. Blood pressure arterial rigidity and risks of stroke. The Framingham study. JAMA 1981; 245; 1225-9.

102. KEYS A., Seven countries. A multivariate analysis of death and coronary heart disease Cambridge (Man): Harvard University Press, 1980.

103. JACOTOT B, LASERIE M, ESLEVA O, BAUDET MF, DACHET C. Corps gras alimentaires et prévention des maladies vasculaires. Etude chez le sujet sain. Rev. Fr Corps gras 1985, 32 : 11-7.

104. DE BACKER G (chairperson), AMBROSIONIE, BORCH-JOH SEN K, BROTONS C,CIFKOVAR, DALLONGEUILLE J, EBRAHIMS et al. European guidelines on cardiovascular. Prevention and rehabilitation 2003; 10 (suppl 1): 51-578.

105. GUIDELINES SUBCOMITTEE 1999 World Health Organization International Society of Hypertension Guidelines for management of hypertension. J. hypertens 1999; 17: 151-183.

106. American College of Sports Medicine. Physical activity, fitness and hypertension. Medicine and Science in Sports and Exercise, 25 (10),i-x.

107. KONO S, SHINKI K, IKEDA M, YANAI F. Lifestyles, glucose tolerance and blood pressure in male self-defence officials in northern Kyushu, Japan. J Hum Hypertens 1992; 6:101-105.

108. TIPTON C.M., Exercise training and hypertension: An up date. Exercise and sport science reviews, 19, 447-505, 1991.

109. STAESSEN J.A, FAGARD R, AMERY A. Life style as a determinant of blood pressure in the general population. AM J Hypertens 1994; 7:685-694

110. ARAKAWA K. Effect of exercise on hypertension and associated complication. Hypertens Res 1996; 19 (suppl.1);587-591.

111. HEYDEN S. Diabetes mellitus in preventives cardiology.Results from intervention studies, Ed.Boehringer Mannheim Gmbh, 1982; 118-141.

112. LONGO-MBENZA B. Diabète sucré et maladies cardiovasculaires.

Cardiol Trop 1995, 21(82); 37-44

113. GOLDBERG L, Elliot M.L., The effects of physical activity on lipid an lipoprotein levels. Medical clinics of North America, 69,41-55, 1985.

114. HASKELL W.L., The influence of exercise on the concentrations of triglyceride and cholesterol in human plasma. Exercise and sport sciences reviews, 12, 205-244,1984.

115. TRAN Z.V. et WELTMAN A. Differential effects of exercise on serum lipid and lipoprotein levels seen with changes in body weight. Journal of the American Medical Association, 254, 919-924, 1985.

116. DOSMAN J. et al, The use of helium oxygen mixture during maximum expiratory flow to demonstrate obstruction of small air ways in smokers J.Clin.Invest, 55: 1090, 1975

117. KUNS T.G et al Ventilatory muscle endurance training in normal subjects and patients with captic fibrosis. Am Rev Respir. Dis, 113: 853, 1977.

118. LEITH D.E., BRADLEY M.,Ventilatory muscle strength and endurance training , J. Appl. Physiolo, 41: 508, 1976.

119. SONNE L.J and DAVIS J.A.,Incrased exercise performance in patients with severe COPD following inspiratory resistive training chest, 81:436, 1982.

120. PARDY R.L. et al, Respiratory muscle training compared with physiotherapy in chronic airflow limitation. Am rev. resp. Dis, 123: 421, 1981.

121. SPIRO S.G et al, An analysis of the physiological strain of sub maximal exercise in patients with chronic obstructive lung disease. Thorax, 30:415, 1975.

122. MOSER K et al, Results of a comprehensive rehabilitation program: physiological and functional effects on patients with chronic obstructive pulmonary disease. Arch Int Med 140 ; 1596, 1980.